» Articles » PMID: 37171602

Effects of Femtosecond Laser-assisted Minimally Invasive Lamellar Keratoplasty (FL-MILK) on Mild-to-moderate and Advanced Keratoconus

Overview
Specialty Ophthalmology
Date 2023 May 12
PMID 37171602
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To compare the outcomes of femtosecond laser-assisted minimally invasive lamellar keratoplasty (FL-MILK) for mild-to-moderate keratoconus (KC) and advanced KC.

Methods: Prospective case series study. Sixty-three eyes of 56 patients with progressive KC underwent FL-MILK were divided into group 1 [mean keratometry (Kmean) ≤ 53D] and group 2 (Kmean > 53D). Best spectacle-corrected visual acuity (BSCVA), Kmean, maximum keratometry (Kmax), anterior central corneal elevation (ACE), stiffness parameter A1 (SP-A1) and deformation amplitude (DA) were evaluated preoperatively and up to 24 months postoperatively.

Results: Mean BSCVA improved from 0.34 ± 0.13 logMAR preoperatively to 0.25 ± 0.13 logMAR at 24 months postoperatively in group 1 (F = 10.10, P < .0001), and from 0.54 ± 0.31 logMAR to 0.40 ± 0.26 logMAR (F = 9.06, P = .0002) in group 2. Group 2 showed an average Kmax reduction of 10.9 D and an average Kmean reduction of 3.9 D at 24 months postoperatively (both P < .0001), whereas no significant change was observed in group 1. Average ACE decreased from 19.2 ± 10.0 to 5.2 ± 8.4 at 24 months postoperatively in group 1 (F = 28.5, P < .0001), and from 46.2 ± 16.3 to 19.1 ± 9.0 (F = 49.6, P < .0001) in group 2; SP-A1 increased from 53.8 ± 12.7 mmHg/mm to 95.9 ± 20.2 mmHg/mm in group 1 (F = 70.0, P < .0001), and from 38.6 ± 13.4 mmHg/mm to 89.3 ± 18.2 mmHg/mm (F = 96.9, P < .0001) in group 2; DA decreased from 1.30 ± 0.14 mm to 1.17 ± 0.13 mm in group 1 (F = 14.0, P < .0001), and from 1.40 ± 0.16 mm to 1.18 ± 0.10 mm (F = 27.6, P < .0001) in group 2.

Conclusions: FL-MILK can stabilize progressive KC in mild-to-moderate cases and advanced cases at 24-month follow-up. Steeper corneas are more likely to undergo flattening after FL-MILK.

Clinical Trial: Date of registration: July 16, 2017. The title of the trail: www.

Clinicaltrials: gov Trial registration number: NCT03229239. The name of the trial registry: ClinicalTrials.gov.

Citing Articles

Visual rehabilitation using rigid gas permeable contact lenses after femtosecond laser-assisted minimally invasive lamellar keratoplasty in patients with keratoconus.

Zhang J, Lin X, Li Z, Zhong X, Shi W, Du X Sci Rep. 2024; 14(1):25106.

PMID: 39443623 PMC: 11500085. DOI: 10.1038/s41598-024-76819-7.


Tissue addition keratoplasty in keratoconus: Trends and concerns.

Vanathi M Indian J Ophthalmol. 2023; 72(1):1-2.

PMID: 38131560 PMC: 10841780. DOI: 10.4103/IJO.IJO_3157_23.


New dawn for keratoconus treatment: potential strategies for corneal stromal regeneration.

Dou S, Liu X, Shi W, Gao H Stem Cell Res Ther. 2023; 14(1):317.

PMID: 37932824 PMC: 10629149. DOI: 10.1186/s13287-023-03548-5.

References
1.
Mas Tur V, MacGregor C, Jayaswal R, OBrart D, Maycock N . A review of keratoconus: Diagnosis, pathophysiology, and genetics. Surv Ophthalmol. 2017; 62(6):770-783. DOI: 10.1016/j.survophthal.2017.06.009. View

2.
Ferrari G, Rama P . The keratoconus enigma: A review with emphasis on pathogenesis. Ocul Surf. 2020; 18(3):363-373. DOI: 10.1016/j.jtos.2020.03.006. View

3.
Dou S, Wang Q, Zhang B, Wei C, Wang H, Liu T . Single-cell atlas of keratoconus corneas revealed aberrant transcriptional signatures and implicated mechanical stretch as a trigger for keratoconus pathogenesis. Cell Discov. 2022; 8(1):66. PMC: 9276680. DOI: 10.1038/s41421-022-00397-z. View

4.
Mou Y, Qin Q, Huang X, Jin X . Risk factors and severity of keratoconus on the East Coast of China. Int Ophthalmol. 2022; 42(7):2133-2140. DOI: 10.1007/s10792-022-02212-w. View

5.
Yang K, Gu Y, Xu L, Fan Q, Zhu M, Wang Q . Distribution of pediatric keratoconus by different age and gender groups. Front Pediatr. 2022; 10:937246. PMC: 9339668. DOI: 10.3389/fped.2022.937246. View